You are viewing a free summary from Descrybe.ai. For citation checking, legal issue analysis, and other advanced tools, explore our Legal Research Toolkit — not free, but close.

Invitrogen Corp. v. Biocrest Manufacturing

Citation: Not availableDocket: 2004-1273

Court: Court of Appeals for the Federal Circuit; October 5, 2005; Federal Appellate Court

Original Court Document: View Document

Narrative Opinion Summary

On October 5, 2005, the United States Court of Appeals for the Federal Circuit issued an erratum for Appeal No. 04-1273,-1274, involving Invitrogen Corp. and Biocrest Mfg. L.P., as well as Stratagene Holding Corp. and Stratagene, Inc. The corrections made to the precedential opinion include: - On page 7, line 20, the name "Stratagene" was replaced with "Invitrogen." - On page 7, line 23, "Stratagene" was again substituted with "Invitrogen." - On page 8, line 2, "Stratagene’s" was changed to "Invitrogen’s." - On page 8, line 5, "Stratagene" was modified to "Invitrogen." These amendments ensure the accurate representation of the parties involved in the case.

Legal Issues Addressed

Correction of Party Names in Case Law

Application: The correction involved replacing 'Stratagene' with 'Invitrogen' at various places in the opinion to accurately reflect the parties involved in the litigation.

Reasoning: The corrections made to the precedential opinion include: - On page 7, line 20, the name 'Stratagene' was replaced with 'Invitrogen.'

Erratum in Judicial Opinions

Application: The court issued an erratum to correct the names of parties in the precedential opinion to ensure accuracy in the judicial record.

Reasoning: On October 5, 2005, the United States Court of Appeals for the Federal Circuit issued an erratum for Appeal No. 04-1273,-1274, involving Invitrogen Corp. and Biocrest Mfg. L.P., as well as Stratagene Holding Corp. and Stratagene, Inc.